INDBInternet News Database 2.5 Updated just now · 297 sources Show or hide images Light or dark

Sarilumab May Beat Methotrexate to Lower Steroid Use in PMR

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage

Summary

Real-world data suggest sarilumab may offer greater steroid-sparing benefits than methotrexate, although treatment choice still depends on individual patient factors.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Sarilumab May Beat Methotrexate to Lower Steroid Use in PMR

    Real-world data suggest sarilumab may offer greater steroid-sparing benefits than methotrexate, although treatment choice still depends on individual patient factors.

Comments

Comments need JavaScript.